When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Pfizer has clinched a $10 billion deal for obesity drug developer Metsera, capping a fierce biotech bidding war between the New York-based pharma giant and Danish rival Novo Nordisk. Metsera accepted a sweetened offer from Pfizer late on Friday, citing U.S. antitrust risks in Novo's bid that it had previously called superior.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

After reaching an important support level, Epam (EPAM) could be a good stock pick from a technical perspective. EPAM surpassed resistance at the 200-day moving average, suggesting a long-term bullish trend.

Each of my kids collected more than three pounds of candy on Halloween Night. Three-plus pounds!

Tapestry (TPR) stock could be a promising option to capitalize on the momentum. Why? Because it offers strong margins, a low-debt capital structure, and strong momentum.

SAN JOSE, Calif. , Nov. 10, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and CEO, Dr. Amit Kumar, will participate in the upcoming Water Tower Research Fireside Chat Series taking place on Tuesday, November 11, 2025, at 11:00am PT.

Jim Cramer breaks down why he's keeping an eye on shares of Tyson Foods.

While Nvidia ( NASDAQ:NVDA ) has delivered almost 1,200% over the past three years, and Palantir Technologies ( NASDAQ:PLTR ) has outperformed even that, with gains of 2,370%.

Headwinds like weak demand, tariff woes & supply-chain crisis hurt the Zacks Transportation Air Freight & Cargo industry. UPS & FDX are likely to stand out.

F nears its 52-week high after strong earnings, but EV headwinds and guidance cuts test investor conviction.

Sonida Senior Living (SNDA) came out with a quarterly loss of $1.56 per share versus the Zacks Consensus Estimate of a loss of $0.75. This compares to a loss of $0.98 per share a year ago.

FREMONT, Calif., & CLEARWATER, Fla.--(BUSINESS WIRE)--TD SYNNEX (NYSE:SNX) has been named Global Distributor of the Year and Americas Distributor of the Year for its accomplishments in its U.S. business at Cisco Partner Summit 2025. TD SYNNEX was also recognized as Distributor of the Year for the EMEA region through its efforts in Norway, and recognized as Distributor of the Year in both Germany and Norway. In the Americas, TD SYNNEX was recognized as Distributor of the Year for Brazil and Mexi.

eToro Group Ltd (NASDAQ: ETOR) on Monday reported better than expected earnings for its third quarter 2025, boosted by robust user growth and diversified revenue streams. The stock and crypto trading platform posted an adjusted profit of $0.60 per share in the quarter, surpassing the analyst consensus estimate of $0.56, according to data compiled by LSEG.

Retailer expands its presence in Florida, South Carolina, and North Carolina communities with the announcement of five stores MATTHEWS, N.C. , Nov. 10, 2025 /PRNewswire/ -- Harris Teeter is proud to announce its continued growth with the opening of several new store locations across the Harris Teeter region, which include expansion into new markets for the company.

Comcast Corporation offers an attractive income opportunity, with a 4.5%+ dividend yield and a robust payout ratio below 30%. Despite secular declines in broadband and cable TV, CMCSA's wireless, theme parks, and Peacock streaming segments are driving growth and offsetting losses. Valuation is compelling, with a forward PE of ~6.5x and shares trading at a 5-year low, suggesting deep value and limited downside risk.

Archer Aviation remains a promising eVTOL contender, but the recent $650 million capital raise at $8/share raises concerns over capital discipline. ACHR's acquisition of Hawthorne Airport and increased liquidity to $2B appear unnecessary, given its already strong cash position and pre-revenue status. Despite dilution, ACHR's opportunity is validated by a $500 million Korean Air order and plans to launch air taxi services in the UAE.

Pfizer CEO Albert Bourla joins Squawk on the Street to discuss the company's up to $10 billion acquisition of Metsera, the competitive landscape in obesity drugs, and Pfizer's strategy for clinical development and manufacturing.

Asset manager Apollo Global Management (NYSE:APO) has acquired a majority stake in Spanish football team Atlético Madrid in its first move into European football. The current owners of the 11 times La Liga champions, Miguel Ángel Gil, Enrique Cerezo, Quantum Pacific Group and Ares Management funds, have sold a majority stake to Apollo Sports Capital but retained minority positions.

Calumet, Inc. is balancing specialty chemicals with a growing renewables business, highlighted by operational improvements and a strong Montana Renewables segment. CLMT's Q3 saw cost reductions, record specialty segment production, and progress in renewable fuels, but high interest expense still drives pretax losses. Valuation appears stretched on an EV/EBITDA basis, with negative levered free cash flow due to debt, despite positive unlevered free cash flow and operational gains.